Pain Management & Neurology
Chronic Pain
Chronic pain affects millions worldwide, significantly impacting quality of life and daily functioning. CenExel partners with sponsors to advance innovative therapies that address both the physical and neurological aspects of chronic pain—delivering hope to patients across diverse populations.
Studies Conducted
0
+
Trial Participants
0
+
Active Centers
0
Overview
Leading Chronic Pain Clinical Research
Chronic pain research requires specialized scientific knowledge and patient-centered execution. CenExel’s experienced teams integrate clinical expertise, advanced trial design, and operational excellence to ensure efficient study delivery.
Our research spans a wide range of chronic pain conditions, incorporating innovative endpoints, patient-reported outcomes, and biomarker strategies to improve trial success.
We support studies across diverse populations, including adult, geriatric, and underserved patient groups.
Conditions Covered
Chronic Pain Conditions We Research
Our chronic pain research sites support a broad spectrum of conditions, addressing both acute and long-term pain disorders.
Neuropathic Pain
Fibromyalgia
Chronic Lower Back Pain
Migraine & Chronic Headache
Osteoarthritis Pain
Rheumatoid Arthritis Pain
Cancer-Related Pain
Post-Surgical Pain
Complex Regional Pain Syndrome (CRPS)
Diabetic Neuropathy
Our Approach
Why Sponsors Choose CenExel for Chronic Pain
Our expertise extends beyond enrollment—we provide scientific insight, operational precision, and high-quality data for regulatory success.
01
Pain Assessment Expertise
Our teams utilize validated pain scales, digital endpoints, and patient-reported outcomes to ensure accurate and reliable data collection.
02
Advanced Trial Design
We support adaptive trial designs, biomarker integration, and innovative methodologies to improve efficiency and outcomes.
03
Diverse Patient Access
Access to diverse patient populations across multiple U.S. regions ensures representative and inclusive clinical trials.
04
Proven Enrollment Success
Our recruitment strategies consistently meet and exceed enrollment goals, even for complex chronic pain studies.
Phase Coverage
Supported Trial Phases
CenExel supports chronic pain trials across all phases—from early-stage first-in-human studies to large-scale Phase IV and post-marketing research.
Active across all phases
Phase I
Phase II
Phase III
Phase IV
Our early phase capabilities include pharmacodynamic biomarker strategies, first-in-human studies, and proof-of-concept trial design — guided by Chief Scientific Officer Dr. Larry Ereshefsky, an internationally recognized KOL in CNS research with over 30 years of early phase expertise.
Let’s Advance Your Next Study
Looking for an experienced clinical research partner with the expertise, capabilities, and reach to move your study forward? Connect with CenExel to discuss your needs and explore how our network can support your clinical development goals.
Explore Our Network
Discover CenExel’s Centers of Excellence and find the locations, therapeutic expertise, and capabilities that align with your clinical development needs.
View More
Therapeutic Area
Dermatology
Skin conditions affect millions worldwide, impacting both health and quality of life.
Therapeutic Area
ENT Clinical Research
ENT disorders impact millions worldwide, affecting breathing, hearing, and quality of life.
Therapeutic Area
Gastroenterology
In the U.S., millions of patients are affected by gastrointestinal disorders, ranging from chronic conditions like IBS and IBD